tiprankstipranks
Trending News
More News >
Molina Healthcare (MOH)
NYSE:MOH
US Market
Advertisement

Molina Healthcare (MOH) Ratios

Compare
965 Followers

Molina Healthcare Ratios

MOH's free cash flow for Q2 2025 was $0.10. For the 2025 fiscal year, MOH's free cash flow was decreased by $ and operating cash flow was $0.03. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.66 1.54 1.47 1.43 1.59
Quick Ratio
1.66 1.54 1.47 1.88 1.96
Cash Ratio
0.57 0.59 0.58 0.63 0.84
Solvency Ratio
0.11 0.12 0.10 0.08 0.10
Operating Cash Flow Ratio
0.07 0.20 0.11 0.30 0.38
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 1.51B$ 1.86B$ 734.00M$ 485.00M$ 440.00M
Leverage Ratios
Debt-to-Assets Ratio
0.22 0.16 0.19 0.20 0.25
Debt-to-Equity Ratio
0.77 0.57 0.81 0.91 1.12
Debt-to-Capital Ratio
0.44 0.36 0.45 0.48 0.53
Long-Term Debt-to-Capital Ratio
0.42 0.34 0.42 0.45 0.50
Financial Leverage Ratio
3.52 3.53 4.15 4.64 4.55
Debt Service Coverage Ratio
9.64 12.58 9.80 7.58 8.46
Interest Coverage Ratio
10.73 14.43 10.66 8.50 10.57
Debt to Market Cap
0.36 0.10 0.11 0.12 0.17
Interest Debt Per Share
68.45 42.78 43.27 43.46 41.59
Net Debt to EBITDA
-0.50 -1.41 -1.20 -1.82 -1.57
Profitability Margins
Gross Profit Margin
10.94%12.72%12.28%11.81%13.78%
EBIT Margin
3.81%4.62%3.67%3.58%5.47%
EBITDA Margin
4.27%5.12%4.22%4.05%5.93%
Operating Profit Margin
3.81%4.62%3.67%3.67%5.55%
Pretax Profit Margin
3.45%4.30%3.32%3.15%4.95%
Net Profit Margin
2.60%3.20%2.48%2.37%3.46%
Continuous Operations Profit Margin
2.60%3.20%2.48%2.37%3.46%
Net Income Per EBT
75.38%74.52%74.51%75.31%70.03%
EBT Per EBIT
90.68%93.07%90.62%85.78%89.15%
Return on Assets (ROA)
6.97%7.33%6.43%5.40%7.06%
Return on Equity (ROE)
24.86%25.88%26.72%25.06%32.11%
Return on Capital Employed (ROCE)
19.84%23.39%21.49%19.76%23.60%
Return on Invested Capital (ROIC)
14.95%17.32%16.01%14.88%16.53%
Return on Tangible Assets
8.05%8.12%7.25%6.01%7.83%
Earnings Yield
11.91%5.18%4.15%3.58%5.36%
Efficiency Ratios
Receivables Turnover
11.23 10.98 13.89 12.76 11.62
Payables Turnover
34.74 23.75 31.55 29.09 26.12
Inventory Turnover
0.00 0.00 0.00 -7.65 -8.93
Fixed Asset Turnover
142.34 108.86 123.45 70.13 49.68
Asset Turnover
2.68 2.29 2.60 2.27 2.04
Working Capital Turnover Ratio
8.40 8.96 10.24 9.37 6.93
Cash Conversion Cycle
21.99 17.89 14.71 -31.66 -23.42
Days of Sales Outstanding
32.50 33.25 26.28 28.61 31.42
Days of Inventory Outstanding
0.00 0.00 0.00 -47.72 -40.87
Days of Payables Outstanding
10.51 15.37 11.57 12.55 13.97
Operating Cycle
32.50 33.25 26.28 -19.11 -9.45
Cash Flow Ratios
Operating Cash Flow Per Share
9.89 28.51 13.37 36.66 32.03
Free Cash Flow Per Share
7.86 27.07 11.80 35.33 30.78
CapEx Per Share
2.03 1.44 1.57 1.33 1.25
Free Cash Flow to Operating Cash Flow
0.80 0.95 0.88 0.96 0.96
Dividend Paid and CapEx Coverage Ratio
4.88 19.79 8.49 27.52 25.54
Capital Expenditure Coverage Ratio
4.88 19.79 8.49 27.52 25.54
Operating Cash Flow Coverage Ratio
0.15 0.70 0.32 0.89 0.80
Operating Cash Flow to Sales Ratio
0.01 0.05 0.02 0.08 0.10
Free Cash Flow Yield
4.51%7.49%3.57%11.11%14.47%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
8.40 19.31 24.10 27.90 18.65
Price-to-Sales (P/S) Ratio
0.22 0.62 0.60 0.66 0.65
Price-to-Book (P/B) Ratio
2.06 5.00 6.44 6.99 5.99
Price-to-Free Cash Flow (P/FCF) Ratio
22.18 13.35 27.99 9.00 6.91
Price-to-Operating Cash Flow Ratio
17.67 12.67 24.69 8.68 6.64
Price-to-Earnings Growth (PEG) Ratio
-3.62 0.53 1.19 -318.32 -5.02
Price-to-Fair Value
2.06 5.00 6.44 6.99 5.99
Enterprise Value Multiple
4.60 10.67 12.95 14.51 9.34
Enterprise Value
8.53B 18.60B 17.47B 16.34B 10.75B
EV to EBITDA
4.60 10.67 12.95 14.51 9.34
EV to Sales
0.20 0.55 0.55 0.59 0.55
EV to Free Cash Flow
19.99 11.79 25.62 8.00 5.92
EV to Operating Cash Flow
15.89 11.19 22.60 7.71 5.69
Tangible Book Value Per Share
44.84 47.44 27.23 23.84 19.58
Shareholders’ Equity Per Share
84.77 72.30 51.28 45.50 35.53
Tax and Other Ratios
Effective Tax Rate
0.25 0.25 0.25 0.25 0.30
Revenue Per Share
799.50 584.43 553.18 480.47 329.20
Net Income Per Share
20.81 18.71 13.70 11.40 11.41
Tax Burden
0.75 0.75 0.75 0.75 0.70
Interest Burden
0.91 0.93 0.91 0.88 0.90
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.07 0.07 0.07 0.07 0.08
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
0.48 1.52 0.98 3.22 2.81
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis